CYPH - Cytoclonal Pharmaceutics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYPH - Cytoclonal Pharmaceutics

CYPH 0.981

-19.2%

Dec 17 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bob Walsh who wrote (126)	6/3/1998 8:41:00 PM
From: blackmerlin	Read Replies (1) of 428

Cytoclonal Pharmaceutics and a Trickle of Paclitaxel Bob: What good news are you talking about? Cytoclonal's own publications and those in the natural products field that attend conferences know that at most the fungus Taxomyces andreanae produced paclitaxel in the microgram/L range if it produces it at all. To be competitive with other sources of paclitaxel the process would have to be brought up to the 500 mg to 1g/L paclitaxel range. A long ways off. Why would anyone seriously make a deal with CYPH? We all have wishes, but unfortunately, they don't all come true.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next